Bioactive peptide concentrates from enzyme-hydrolysed agri-food side-streams
Proprietary bioactive peptide concentrates produced through controlled enzymatic hydrolysis of agri-food side-streams, offering validated functional benefits for food, cosmetic, pharmaceutical, and animal-nutrition applications. Scalable from lab to 200 L pilot plant with a credible pathway to commercial production.
Overview
Valogen Biosciences Ltd produces bioactive peptide concentrates through controlled enzymatic hydrolysis of underutilised agri-food side-streams and other substrates. These proprietary concentrates deliver improved functional properties—including solubility, viscosity, heat stability, flavour enhancement, and ingredient functionality—across food, pharmaceutical, cosmetic, and animal-feed applications.
The technology transforms low-value agricultural by-products into high-value, scientifically validated, allergen-free ingredients, applying circular economy principles to create sustainable biorenewables. Demonstrated applications include hair conditioning in cosmetics, savoury flavour enhancement in food products, and anti-inflammatory and wound-healing properties in healthcare settings.
Technical specifications
Key features:
- Proprietary enzymatic hydrolysis process applicable to plant-based and egg-derived feedstocks, with a credible path to food-compatible operation
- Pilot-scale production capability at 200 L, with a defined scale-up pathway to 1,000 and 10,000 L vessels
- Peptide fractionation to identify bioactive fractions with desired properties, supported by De Novo Sequencing analysis
- Individual peptide synthesis to confirm the identification of active components
- Downstream processing adapted for each application, combining fractions to achieve required performance and good manufacturing yield
- Potential to serve as a platform for evaluating different substrates, with an active research program validating muscle regeneration benefits of canola peptide concentrate in human trials
Technology readiness level
The technology has progressed from laboratory concepts to functional pilot-scale manufacturing at 200 L. A lead product, NutraPep (Canola Peptide Concentrate), is undergoing in vivo human trials in partnership with the Universities of Plymouth and Exeter to validate muscle regeneration efficacy. The company's approach is to develop technologies to TRL 6 and beyond with contract manufacturing organisations and strategic manufacturing partners, establishing a credible pathway toward 1,000 and 10,000 L commercial-scale production.
About Valogen Biosciences Ltd
Valogen Biosciences Ltd is an agritech company that transforms underutilised agri-food side-streams, such as rapeseed meal, into high-value bioactive peptides. The company employs a proprietary, scalable process—developed through extensive research and pilot plant operations—to extract and purify these materials. Their technology allows for the creation of functional ingredients that serve as alternatives to traditional, lower-value applications of agricultural by-products, focusing on delivering scientifically validated, highly digestible, and allergen-free components. By leveraging circular economy principles, the company aims to convert waste streams into sustainable, high-value biorenewables.
The company provides innovative solutions for the nutrition, personal care, and medical sectors. Their bioactive peptides have demonstrated efficacy in various applications, including as hair conditioners in cosmetics, savoury flavour enhancers in food products, and agents with anti-inflammatory and wound-healing properties in healthcare. Valogen works with industrial partners and research institutions to validate their products and scale production, having progressed from laboratory concepts to functional pilot-scale manufacturing. Their business strategy relies on continuous R&D, strategic grants, and partnerships to support their transition toward larger, commercial-scale production facilities.
delivered to your inbox.